<div xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.w3.org/1999/xhtml ../../schema/fhir-xhtml.xsd" xmlns="http://www.w3.org/1999/xhtml">

<h3>References</h3>

<ul>
<li>
Adverse Reaction, draft archetype, National eHealth Transition Authority [Internet]. NEHTA Clinical Knowledge Manager. Authored: 08 Nov 2010. Available at: <a href="http://dcm.nehta.org.au/ckm/OKM.html#showarchetype_1013.1.868_7">http://dcm.nehta.org.au/ckm/OKM.html#showarchetype_1013.1.868_7</a> (accessed Jan 16, 2012).
</li>
<li>
Allergy and Intolerance Domain Analysis Model, Release 1, HL7 [Internet]. Publication pending, expected August 2014; Available at <a href="http://wiki.hl7.org/images/1/1b/Allergy_and_Intolerance_INFORM_2013_MAY.pdf">http://wiki.hl7.org/images/1/1b/Allergy_and_Intolerance_INFORM_2013_MAY.pdf</a> (accessed 06 July 2014). 
</li>
<li>
Allergy, clinical element model, GE/Intermountain Healthcare. Clinical Element Model Search. Available at: <a href="http://intermountainhealthcare.org/cem/Pages/Detail.aspx?NCID=520861661&amp;k=allergy">http://intermountainhealthcare.org/cem/Pages/Detail.aspx?NCID=520861661&amp;k=allergy</a> (accessed Jan 16, 2012).
</li>
<li>
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000 Oct 7;356(9237):1255-9. PubMed PMID: 11072960. 
</li>
<li>
Horsfield P, Sibeko S. Representation in Electronic Patient Records of Allergic Reactions, Adverse Reactions, and Intolerance of Pharmaceutical Products [Internet]. London, UK: National Health Service; 2006 Sep 07 [cited 2011 Jun 21]; Available at <a href="https://svn.connectingforhealth.nhs.uk/svn/public/nhscontentmodels/TRUNK/ref/NPfIT/Allergy_ADR_Intolerance%20v%201.2Final.doc">https://svn.connectingforhealth.nhs.uk/svn/public/nhscontentmodels/TRUNK/ref/NPfIT/Allergy_ADR_Intolerance%20v%201.2Final.doc</a>.
</li>
<li>
Long R, Bentley S. SCG Guidance on the Representation of Allergies and Adverse Reaction Information Using NHS Message Templates [Internet]. London, UK: National Health Service; 2008 Apr 30 [cited 2011 Jun 21]; Available at <a href="http://www.connectingforhealth.nhs.uk/systemsandservices/data/scg/scg0001.pdf">http://www.connectingforhealth.nhs.uk/systemsandservices/data/scg/scg0001.pdf</a>.
</li>
<li>
Microsoft. Design Guidance: Displaying Adverse Drug Reaction Risks [Internet]. 2009 January 28 [cited 2011 Jun 21]; Available at <a href="http://www.mscui.net/DesignGuide/DisplayingAllergies.aspx">www.mscui.net/DesignGuide/DisplayingAllergies.aspx</a>.
</li>
<li>
Microsoft. Design Guidance: Recording Adverse Drug Reaction Risks [Internet]. 2009 March 27 [cited 2011 Jun 21]; Available at <a href="http://www.mscui.net/DesignGuide/RecordingAllergies.aspx">www.mscui.net/DesignGuide/RecordingAllergies.aspx</a>.
</li>
<li>
Mosby. Mosby's Pocket Dictionary of Medicine, Nursing and Health Professions. 6th Edition. USA: Mosby Elsevier; 2010
</li>
<li>
National E-Health Transition Authority. Adverse Reactions (Data Specifications) Version 1.1 [Internet]. Sydney, Australia: NEHTA; 2008 Feb 29 [cited 2011 Jun 21]; Available at <a href="http://www.nehta.gov.au/component/docman/doc_download/453-adverse-reaction-data-specification-v11">http://www.nehta.gov.au/component/docman/doc_download/453-adverse-reaction-data-specification-v11</a>
</li>
<li>
Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician. 2003 Nov 1;68(9):1781-90. Review. PubMed PMID: 14620598.
</li>
<li>
Royal Australian College of General Practitioners. Fact Sheet: Allergies &amp; Adverse Reactions (Draft). 2010.
</li>
<li>
Thien FC. Drug hypersensitivity. Med J Aust. 2006 Sep 18;185(6):333-8. Review. PubMed PMID: 16999678.
</li>
<li>
Uppsala Monitoring Centre (WHO): <a href="http://www.who-umc.org/">http://www.who-umc.org/</a>
</li>
<li>
European Medicines Agency: <a href="http://www.ema.europa.eu/ema/">http://www.ema.europa.eu/ema/</a>
</li>
<li>
DIRECTIVE 2010/84/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL, of 15 December 2010, amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use: <a href="http://ec.europa.eu/health/files/eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf">http://ec.europa.eu/health/files/eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf</a>
</li>
</ul>

</div>
